Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123111 | PMC |
| http://dx.doi.org/10.3109/01658107.2014.886076 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Proceedings of the 46 Annual Upper Midwest Neuro-Ophthalmology Group Meeting.
Neuroophthalmology
September 2024
Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA.
The 46th meeting of the Upper Midwest Neuro-Ophthalmology Group (UMNOG), held on July 26, 2024, and hosted by Northwestern University at Chicago, brought together a group of neuro-ophthalmologists, researchers, and trainees. This conference served as a forum for presenting research findings, illustrating challenging cases in clinical practice, and discussing them from an expert viewpoint. Key topics included visual outcomes following the treatment of various optic neuropathies, and advancements in diagnostic techniques, including the integration of machine learning.
View Article and Find Full Text PDFFinal report of the phase II NEXT/CNS-GCT-4 trial: GemPOx followed by marrow-ablative chemotherapy for recurrent intracranial germ cell tumors.
Neurooncol Pract
April 2024
Division of Hematology, Oncology, Blood and Marrow Transplant, Nationwide Children's Hospital and Ohio State University College of Medicine, Columbus, Ohio, USA.
Background: Patients with relapsed intracranial germinoma can achieve durable remission with standard chemotherapy regimens and/or reirradiation; however, innovative therapies are required for patients with relapsed and/or refractory intracranial nongerminomatous germ cell tumors (NGGCTs) due to their poor prognosis. Improved outcomes have been reported using reinduction chemotherapy to achieve minimal residual disease, followed by marrow-ablative chemotherapy (HDCx) with autologous hematopoietic progenitor cell rescue (AuHPCR). We conducted a phase II trial evaluating the response and toxicity of a 3-drug combination developed for recurrent intracranial germ cell tumors consisting of gemcitabine, paclitaxel, and oxaliplatin (GemPOx).
View Article and Find Full Text PDFRelapsing White Matter Disease and Subclinical Optic Neuropathy: From the National Multiple Sclerosis Society Case Conference Proceedings.
Neurol Neuroimmunol Neuroinflamm
March 2024
From the Department of Neurology (K.A.O., A.D., N.J.A., L.J.B., S.G., I.K., C.M., J.R., C.M.W., S.N.G., L.B.K.); Department of Ophthalmology (A.D.); Division of Neurogenetics (NJA, CS); Department of Ophthalmology (L.J.B., S.G., S.N.G.); Department of Population Health (L.J.B.); Department of Radiology (M.B.), NYU Grossman School of Medicine, New York, NY; Department of Neurosciences (J.G.), University of California, San Diego; Department of Pathology (C.M.), Weill Cornell Medicine, New York, NY; Department of Neurology (S.D.N.), Johns Hopkins University, Baltimore, MD; Departments of Pediatrics (J.P.) and Pathology (C.M.W.), NYU Grossman School of Medicine, New York, NY; and Department of Neurology (S.S.Z.), University of California, San Francisco.
A 16-year-old adolescent boy presented with recurrent episodes of weakness and numbness. Brain MRI demonstrated subcortical, juxtacortical, and periventricular white matter T2 hyperintensities with gadolinium enhancement. CSF was positive for oligoclonal bands that were not present in serum.
View Article and Find Full Text PDFProceedings of the 45th Annual Upper Midwest Neuro-Ophthalmology Group Meeting, 21 July 2023.
Neuroophthalmology
September 2023
Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA.
Consensus statement on concussion in sport: the 6th International Conference on Concussion in Sport-Amsterdam, October 2022.
Br J Sports Med
June 2023
National Hockey League, New York, New York, USA.
Article Synopsis
- The 6th International Conference on Concussion in Sport took place in Amsterdam from October 27-30, 2022, leading to a new consensus statement and updates on concussion protocols.
- In preparation, author groups conducted extensive systematic reviews over 3½ years on key concussion-related topics, informing the conference discussions and outcomes.
- The conference introduced revised tools like CRT6 and SCAT6, emphasized the importance of the para athlete's perspective, and highlighted gaps in research concerning concussion prevention and long-term effects.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!